Arca
Skip to content
Tools
Tools

ADRB2: Beta-2 adrenergic receptor

G protein-coupled receptor for catecholamines that couples to both G(s) and G(i) proteins, activating bifurcated signaling pathways.

  • Drugs that act on it: 52
  • Approved: 32
  • In phases 1 to 3: 20
  • Sponsors: 24

Who is on it, and how far along

Every drug ChEMBL records acting on ADRB2, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 50
  • Other 2

Approved32

Phase 32

Phase 216

Phase 12

Sponsors

Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

The landscape

Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 36 of 52 act as: Beta-2 adrenergic receptor agonist; the rest name their own mechanism.
PropranololBoxed warningApprovedPfizerSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist86
AlbuterolBoxed warningApprovedChia Tai Tianqing Pharmaceutical GroupSmall moleculeAgonist52
LevosalbutamolBoxed warningApprovedSanofiSmall moleculeAgonist52
ArformoterolApprovedLupinSmall moleculeAgonist44
FormoterolApprovedNovartis PharmaceuticalsSmall moleculeAgonist44
DobutamineApprovedEli LillySmall moleculeAgonist26
TimololApprovedTavo BiotherapeuticsSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist24
VilanterolApprovedGSKSmall moleculeAgonist16
EsmololWithdrawnApprovedBaxter InternationalSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist15
SalmeterolBoxed warningApprovedChiesi FarmaceuticiSmall moleculeAgonist14
SotalolBoxed warningApprovedLEGACYSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist14
NebivololApprovedAbbVieSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist13
PropafenoneBoxed warningApprovedGSKSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist11
IndacaterolApprovedNovartis PharmaceuticalsSmall moleculeAgonist8
DilevalolWithdrawnApproved—Small moleculeAgonist5
NadololBoxed warningApprovedUSWMSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist4
TerbutalineBoxed warningApprovedSanofiSmall moleculeAgonist4
PindololApprovedNovartis PharmaceuticalsSmall moleculePartial agonistBeta-2 adrenergic receptor partial agonist3
CeliprololApprovedAcer TherapeuticsSmall moleculePartial agonistBeta-2 adrenergic receptor partial agonist1
OlodaterolApprovedBoehringer Ingelheim PharmaceuticalsSmall moleculeAgonist1
PenbutololApprovedEndo InternationalSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist1
BitolterolApprovedSanofiSmall moleculeAgonist0
FenoterolWithdrawnApprovedBoehringer Ingelheim PharmaceuticalsSmall moleculeAgonist0
IsoetharineApproved—Small moleculeAgonist0
LevobunololApprovedAbbVieSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist0
MetaproterenolWithdrawnApprovedBoehringer Ingelheim PharmaceuticalsSmall moleculeAgonist0
MetipranololWithdrawnApprovedBausch & LombSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist0
OxprenololApprovedNovartis PharmaceuticalsSmall moleculeAntagonistBeta-2 adrenergic receptor antagonist0
PirbuterolApprovedBausch HealthSmall moleculeAgonist0
PronetalolWithdrawnApproved—Small moleculeAntagonistBeta-2 adrenergic receptor antagonist0
ProtokylolApproved—Small moleculeAgonist0
RitodrineApprovedAstraZeneca PharmaceuticalsSmall moleculeAgonist0
ProcaterolPhase 3AstraZeneca PharmaceuticalsSmall moleculeAgonist4
BambuterolPhase 3—Small moleculeAgonist0
ClenbuterolPhase 2CuraSen Therapeutics, Inc.Small moleculeAgonist2
TulobuterolPhase 2SamA Pharmaceutical Co., LtdSmall moleculeAgonist1
AbediterolPhase 2AstraZeneca PharmaceuticalsSmall moleculeAgonist0
AZD3199Phase 2AstraZeneca PharmaceuticalsOtherAgonist0
BatefenterolPhase 2GSKSmall moleculeAgonist0
BedoradrinePhase 2MediciNovaSmall moleculeAgonist0
BucindololPhase 2ARCA Biopharma, Inc.Small moleculeAntagonistBeta-2 adrenergic receptor antagonist0
CarmoterolPhase 2Chiesi FarmaceuticiSmall moleculeAgonist0
IsoxsuprinePhase 2—Small moleculeAgonist0
LY377604Phase 2Eli LillySmall moleculeAntagonistBeta-2 adrenergic receptor antagonist0
MilveterolPhase 2GSKSmall moleculeAgonist0
NavafenterolPhase 2AstraZeneca PharmaceuticalsSmall moleculeAgonist0
PF-00610355Phase 2PfizerSmall moleculeAgonist0
ReproterolPhase 2ViatrisSmall moleculeAgonist0
RimiterolPhase 2—Small moleculeAgonist0
Vilanterol .alpha.-phenyl cinnamatePhase 2GSKSmall moleculeAgonist0
GSK159802Phase 1GSKOtherAgonist0
LAS190792Phase 1AstraZeneca PharmaceuticalsSmall moleculeAgonist0

Open trials

The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 111 in all, from ClinicalTrials.gov.
Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial)PropafenoneNot applicableNot yet recruitingKorea University Anam HospitalNov 16, 2026
An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent AsthmaArformoterol, FormoterolPhase 3Not yet recruitingAstraZenecaNov 13, 2026
Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)Arformoterol, Formoterol—Not yet recruitingAstraZenecaNov 12, 2026
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.TimololPhase 2RecruitingTavo BiotherapeuticsNov 3, 2026
Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind StudyPropranololPhase 3RecruitingFundació d'investigació Sanitària de les Illes BalearsOct 27, 2026
Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD PatientsIndacaterolPhase 2RecruitingAeroRx Therapeutics Inc.Oct 26, 2026
Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung CancerPropranololPhase 1RecruitingSecond Xiangya Hospital of Central South UniversityOct 21, 2026
Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung CancerPropranololPhase 1RecruitingSecond Xiangya Hospital of Central South UniversityOct 21, 2026
Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial FibrillationAlbuterol, LevosalbutamolNot applicableRecruitingChina National Center for Cardiovascular DiseasesOct 16, 2026
Cardiocentric Inotropic Optimization in Spinal Cord InjuryDobutamineEarly phase 1Not yet recruitingUniversity of British ColumbiaOct 13, 2026
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With AsthmaArformoterol, Formoterol, SalmeterolPhase 3Not yet recruitingChiesi Farmaceutici S.p.A.Oct 5, 2026
Efficacy of Cognitive Behavioral Therapy at Vestibular MigrainePropranololNot applicableNot yet recruitingSohag UniversitySep 30, 2026
Esmolol Versus Dexmedetomidine for Opioid-sparing in Laparoscopic Gynecological SurgeryEsmololNot applicableRecruitingVasiliki SamartziSep 29, 2026
Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma PatientsTimololPhase 4RecruitingBrett KingSep 29, 2026
Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular CancerPropranololPhase 2Not yet recruitingUniversity of Southern CaliforniaSep 23, 2026
Renal Oxygenation-Guided AKI Reduction TrialDobutamineNot applicableNot yet recruitingChinese PLA General HospitalSep 14, 2026
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using PropranololPropranololPhase 3Not yet recruitingUniversity Hospital, ToulouseAug 28, 2026
Beclometasone Dipropionate and Formoterol Inhalation Aerosol for AsthmaArformoterol, FormoterolPhase 3RecruitingLunan Better Pharmaceutical Co., LTD.Aug 17, 2026
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockDobutamineNot applicableNot yet recruitingLeipzig Heart Science gGmbHAug 13, 2026
Preventive Role of Melatonin and Propranolol Administration in Pediatric MigrainePropranololNot applicableEnrolling by invitationNishtar Medical UniversityAug 3, 2026
Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ AdenocarcinomaPropranololPhase 1 / Phase 2Not yet recruitingTing LiuJul 27, 2026
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)Arformoterol, Formoterol, Albuterol, LevosalbutamolPhase 4Not yet recruitingUniversity of Tennessee Graduate School of MedicineJul 23, 2026
Clearance in Primary Ciliary DyskinesiaAlbuterol, LevosalbutamolNot applicableNot yet recruitingUniversity of North Carolina, Chapel HillJul 13, 2026
Dorzolamide/Brimonidine/Timolol Impact on Ocular Surface, Glaucoma Progression & Chatbot Follow-up: GLAUCO-TECHTimololPhase 4Active, not recruitingTecnoquimicasJul 8, 2026
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])Arformoterol, FormoterolPhase 4RecruitingChiesi Farmaceutici S.p.A.Jun 24, 2026
Remifentanil vs Esmolol During Intubation for Cerebral Aneurysm Coil EmbolizationEsmololNot applicableNot yet recruitingFatih Sultan Mehmet Training and Research HospitalJun 22, 2026
Effects of Esmolol on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic ShockEsmololNot applicableNot yet recruitingFirst Affiliated Hospital of Wannan Medical CollegeJun 18, 2026
Fasenra: An Asthma StudyAlbuterol, LevosalbutamolPhase 4Enrolling by invitationEndeavor HealthJun 17, 2026
Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle GlaucomaTimololPhase 3Not yet recruitingAche Laboratorios Farmaceuticos S.A.Jun 1, 2026
Estimation of the Prevalence of Microcirculatory Dysfunction in Uremic Cardiopathy Among Dialysis PatientsDobutamineNot applicableNot yet recruitingCentre Hospitalier Departemental VendeeMay 27, 2026
Efficacy of Early Rhythm Control in AF With TR PatientsPropafenone, Sotalol—RecruitingSamsung Medical CenterMay 26, 2026
Opioid-free Anesthesia and Postoperative DeliriumEsmololPhase 1Not yet recruitingQianfoshan HospitalMay 22, 2026
An Exploratory Study on Triple Inhaler Therapy in Patients With Early Lung Function ImpairmentArformoterol, FormoterolNot applicableNot yet recruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityMay 19, 2026
The Role Intraoperative Salbutamol Inhaler in Preventing AtelectasisAlbuterol, LevosalbutamolEarly phase 1Not yet recruitingKing Abdullah University HospitalMay 15, 2026
The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label TrialTimololPhase 2Not yet recruitingGeisinger ClinicMay 13, 2026
Bilevel Positive Airway Pressure (BPAP) for Severe AsthmaAlbuterol, LevosalbutamolNot applicableNot yet recruitingColumbia UniversityMay 12, 2026
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesNebivololNot applicableEnrolling by invitationEnhanced Emirates LimitedMay 6, 2026
Psilocybin Administration With 5-HT1a BlockadePindololEarly phase 1RecruitingJohns Hopkins UniversityMay 4, 2026
Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonistsArformoterol, FormoterolPhase 3RecruitingChiesi Farmaceutici S.p.A.Apr 23, 2026
The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.NebivololPhase 4RecruitingZiekenhuis Oost-LimburgApr 7, 2026
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantTimololPhase 3RecruitingGlaukos CorporationMar 27, 2026
Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine SurgeryEsmolol—RecruitingMarmara UniversityMar 23, 2026
Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne VulgarisTimololEarly phase 1RecruitingPham Ngoc Thach University of MedicineMar 16, 2026
Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial FibrillationPropafenone, SotalolNot applicableRecruitingSamsung Medical CenterMar 3, 2026
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular ComplexesSotalolNot applicableRecruitingWestern Sydney Local Health DistrictMar 3, 2026
Artificial Intelligence Stress Echo (FINESSE) ProjectDobutamine—Active, not recruitingMilton Keynes University Hospital NHS Foundation TrustFeb 25, 2026
Ventilation and Perfusion in AsthmaticsAlbuterol, LevosalbutamolPhase 4RecruitingUniversity of MiamiFeb 23, 2026
The PROTECT-HIE Pilot TrialDobutaminePhase 2RecruitingUniversity of AlbertaFeb 12, 2026
MEdical Treatment in Idiopathic Ventricular Fibrillation PatientsNadololPhase 4RecruitingBo Gregers WinkelFeb 12, 2026
Flecainide Safety in Patients With Coronary Artery Disease and Atrial FibrillationSotalolPhase 4RecruitingUniversitaire Ziekenhuizen KU LeuvenFeb 12, 2026
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma ExacerbationSalmeterolNot applicableRecruitingJuan Carlos CardetFeb 9, 2026
Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds HealingTimololPhase 2Not yet recruitingUniversity of California, DavisFeb 3, 2026
Effect of Intraoperative Salbutamol Administration on Mechanical Power and Respiratory Mechanics in Obese Patients Undergoing Laparoscopic Bariatric SurgeryAlbuterol, LevosalbutamolNot applicableNot yet recruitingSaglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalJan 30, 2026
Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients Undergoing Major Abdominal Procedures - A Pilot StudyDobutamineNot applicableRecruitingUniversity Hospital DubravaJan 14, 2026
Immuno-inflammatory Response of Erdosteine in COPDVilanterolNot applicableNot yet recruitingPierachille Santus, MD, PhDJan 9, 2026
POCUS-Guided Esmolol in Septic Shock: A Pilot RCTEsmololPhase 1 / Phase 2Not yet recruitingJohn BasmajiJan 2, 2026
Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced HypertensionDobutamine—RecruitingRegion StockholmDec 26, 2025
VENTURI (VENTilation Using Respiratory Imaging)VilanterolPhase 2RecruitingUniversity of Alabama at BirminghamDec 15, 2025
Dronedarone Rhythm Intervention for Early Atrial FibrillationPropafenonePhase 4Not yet recruitingInha University HospitalDec 8, 2025
Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer PatientsNebivololPhase 2RecruitingAin Shams UniversityNov 18, 2025
129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of ExacerbationVilanterolPhase 4RecruitingWestern University, CanadaSep 25, 2025
Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram TrialNadololNot applicableRecruitingUniversity of California, Los AngelesSep 11, 2025
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting BronchodilatorsVilanterolPhase 4RecruitingUniversity of Tennessee Graduate School of MedicineAug 21, 2025
Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO ClosureNebivololNot applicableNot yet recruitingYonsei UniversityAug 14, 2025
Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal CongestionSalmeterolNot applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineAug 11, 2025
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)PindololPhase 2RecruitingActimed Therapeutics LtdAug 3, 2025
Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPDIndacaterol, Olodaterol, Salmeterol, VilanterolNot applicableActive, not recruitingIstanbul Medeniyet UniversityJul 10, 2025
Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy PatientsDilevalolPhase 4Enrolling by invitationAin Shams UniversityJun 24, 2025
Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intubation on an Outpatient BasisEsmololPhase 4RecruitingUniversity Hospital, LimogesJun 13, 2025
Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in PatientsEsmololNot applicableRecruitingPeking University Shenzhen HospitalJun 4, 2025
Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the EDTerbutalinePhase 3RecruitingUniversity of MonastirMay 20, 2025
Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)Nebivolol—RecruitingA.Menarini Asia-Pacific Holdings Pte LtdApr 22, 2025
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm ControlPropafenone, Sotalol—Not yet recruitingKansas City Heart Rhythm Research FoundationJan 20, 2025
Nebivolol ANOCA Treatment Randomized TrialNebivololPhase 3Not yet recruitingSpanish Society of CardiologyJan 1, 2025
Clenbuterol to Target DUX4 in FSHDClenbuterolPhase 1RecruitingJeffrey StatlandDec 6, 2024
Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial FibrillationPropafenoneNot applicableRecruitingSeoul National University HospitalNov 21, 2024
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaSalmeterolPhase 2Active, not recruitingSanofiNov 6, 2024
Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic StrategiesSotalolNot applicableRecruitingIRCCS Ospedale San RaffaeleNov 1, 2024
Urinary Concentration After SalmeterolSalmeterolNot applicableRecruitingUniversity of CopenhagenOct 24, 2024
Salmeterol Effect on Exercise PerformanceSalmeterolNot applicableRecruitingUniversity of CopenhagenOct 23, 2024
Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.SalmeterolNot applicableRecruitingUniversity of CopenhagenOct 23, 2024
Exercise as an Immune Adjuvant for Allogeneic Cell TherapiesNadololEarly phase 1RecruitingUniversity of ArizonaOct 16, 2024
Air Pollution and Inhaled Corticosteroids in COPDVilanterolPhase 4Not yet recruitingUniversity of British ColumbiaAug 14, 2024
The Impact of Airway Allergic Diseases on Children's and Parents' Quality of LifeTerbutaline—RecruitingWenjing ZhouAug 2, 2024
Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection FractionNebivololPhase 3RecruitingAssistance Publique - Hôpitaux de ParisJul 24, 2024
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.ProcaterolPhase 3Active, not recruitingAstraZenecaJun 25, 2024
The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPDVilanterolPhase 3RecruitingMahidol UniversityJun 25, 2024
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary ArteriesNebivololPhase 2 / Phase 3RecruitingStanford UniversityMay 22, 2024
The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis PatientsTulobuterolPhase 4RecruitingSamA Pharmaceutical Co., LtdMay 13, 2024
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaVilanterolPhase 4Active, not recruitingGlaxoSmithKlineApr 18, 2024
Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial FibrillationSotalolNot applicableRecruitingNantes University HospitalMar 20, 2024
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular AtrophyClenbuterolPhase 2RecruitingGianni SoraruDec 13, 2023
Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)PropafenoneNot applicableRecruitingThe First Affiliated Hospital with Nanjing Medical UniversityNov 9, 2023
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationPropafenone, SotalolNot applicableActive, not recruitingBoston Scientific CorporationOct 23, 2023
Role of Lung Function for Exercise Capacity in Well-trained IndividualsIndacaterolNot applicableRecruitingMorten Hostrup, PhDOct 11, 2023
U-LABA/ICS Effects on Exercise Performance, IndacaterolIndacaterolNot applicableRecruitingMorten Hostrup, PhDOct 4, 2023
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.IndacaterolPhase 3RecruitingNovartis PharmaceuticalsMar 20, 2023
A Preliminary Study for INFORMEDNadolol, Penbutolol, PindololPhase 4RecruitingWeill Medical College of Cornell UniversityOct 18, 2022
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaIndacaterolPhase 3RecruitingNovartis PharmaceuticalsSep 30, 2022
Safest Choice of Antihypertensive Regimen for Postpartum HypertensionDilevalolPhase 3RecruitingLoma Linda UniversitySep 22, 2022
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos SyndromeCeliprololPhase 3RecruitingAcer Therapeutics Inc.Jun 27, 2022
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled TrialDilevalolPhase 4RecruitingNebraska Methodist Health SystemApr 4, 2022
A 24-week rPMS Study in Real-world Setting for EnerzairIndacaterol—Active, not recruitingNovartis PharmaceuticalsMar 10, 2022
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®Indacaterol—Active, not recruitingNovartis PharmaceuticalsFeb 1, 2022
Hot Flashes and Neurovascular Function in WomenTerbutalineNot applicableRecruitingMayo ClinicJan 18, 2022
Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild AsthmaProcaterolNot applicableRecruitingIntech Biopharm Ltd.Jun 3, 2021
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early PregnancyDilevalol—RecruitingMarshall UniversityFeb 16, 2021
Preeclampsia Postpartum Antihypertensive TreatmentDilevalolPhase 3Active, not recruitingMedical College of WisconsinMar 6, 2020
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Terbutaline—RecruitingDuke UniversityFeb 20, 2020
Secondhand Smoke Respiratory Health StudyProcaterolPhase 4Active, not recruitingUniversity of California, San FranciscoJun 13, 2016
Lung Disease and Its Affect on the Work of White Blood Cells in the LungsProcaterol—RecruitingUniversity of FloridaMay 10, 2013

Diseases most associated with it

Open Targets association score, 0 to 1; all associations
Asthma
0.63
Hypertensive disorder
0.62
Airway obstruction
0.60
Congestive heart failure
0.60
Cardiovascular disorder
0.60

Genes and related targets

Complexes and families that share a gene with this target
Genes
ADRB2

Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL210, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P07550, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.